The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer

Uncommon Oncogenic Drivers in NSCLC - (ILCN/WCLC)

IJMS, Free Full-Text

The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancer. - Abstract - Europe PMC

Frontiers Recent progress in targeted therapy for non-small cell lung cancer

AMG-510 and cisplatin combination increases antitumor effect in lung adenocarcinoma with mutation of KRAS G12C: a preclinical and translational research

肺癌靶点研究渐露锋芒，源井生物基因编辑细胞助力肿瘤研究_源井生物

The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancer. - Abstract - Europe PMC

Member Detail - DF/HCC

PDF) Correlation between PD-L1 expression and MET gene amplification in patients with advanced non-small-cell lung cancer and no other actionable oncogenic driver